137 related articles for article (PubMed ID: 29492209)
1. EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma.
Osio A; Xu S; El Bouchtaoui M; Leboeuf C; Gapihan G; Lemaignan C; Bousquet G; Lebbé C; Janin A; Battistella M
Oncotarget; 2018 Feb; 9(9):8478-8488. PubMed ID: 29492209
[TBL] [Abstract][Full Text] [Related]
2. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
Szollosi Z; Scholtz B; Egervari K; Nemes Z
J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
[TBL] [Abstract][Full Text] [Related]
3. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
[TBL] [Abstract][Full Text] [Related]
4. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y
Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648
[TBL] [Abstract][Full Text] [Related]
5. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
[TBL] [Abstract][Full Text] [Related]
6. Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
Oh E; Jeong HM; Kwon MJ; Ha SY; Park HK; Song JY; Kim YJ; Choi JS; Lee EH; Lee J; Choi YL; Shin YK
PLoS One; 2017; 12(10):e0185826. PubMed ID: 28977029
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
[TBL] [Abstract][Full Text] [Related]
9. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.
Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M
J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
[TBL] [Abstract][Full Text] [Related]
11. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
[TBL] [Abstract][Full Text] [Related]
12. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
[TBL] [Abstract][Full Text] [Related]
13. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Ugurel S; Mentzel T; Utikal J; Helmbold P; Mohr P; Pföhler C; Schiller M; Hauschild A; Hein R; Kämpgen E; Kellner I; Leverkus M; Becker JC; Ströbel P; Schadendorf D
Clin Cancer Res; 2014 Jan; 20(2):499-510. PubMed ID: 24173542
[TBL] [Abstract][Full Text] [Related]
15. Imatinib in the treatment of dermatofibrosarcoma protuberans.
Labropoulos SV; Razis ED
Biologics; 2007 Dec; 1(4):347-53. PubMed ID: 19707305
[TBL] [Abstract][Full Text] [Related]
16. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans.
Kiuru-Kuhlefelt S; El-Rifai W; Fanburg-Smith J; Kere J; Miettinen M; Knuutila S
Cytogenet Cell Genet; 2001; 92(3-4):192-5. PubMed ID: 11435686
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K; Noujaim J; Jones RL; Fisher C
Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
[TBL] [Abstract][Full Text] [Related]
18. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
19. Primary intrathoracic dermatofibrosarcoma protuberans.
King L; López-Terrada D; Jakacky J; McCarville MB; Spunt SL; Bridge JA; Bahrami A
Am J Surg Pathol; 2012 Dec; 36(12):1897-902. PubMed ID: 23108023
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]